hemicellulose
Botanicalexperimental
A hemicellulose is one of a number of heteropolymers, such as arabinoxylans, present along with cellulose in almost all terrestrial plant cell walls. Cellulose is crystalline, strong, and resistant to hydrolysis. Hemicelluloses are branched, shorter in length than cellulose, and also show a propensity to crystallize. They can be hydrolyzed by dilute acid or base as well as a myriad of hemicellulase enzymes. — Wikipedia
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2006 (NCT00507715)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaHemicellulose ↗
Also known as
- hemicellulose
- hemicellulose
- hemicellulose crystalline
- masonex
- veloderm
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02690103 | Phase 2 | Jul 1, 2012 | Cairo University, Daiwa Pharmaceutical Corporation, University of California, Los Angeles |
| NCT00507715 | Phase 1 | Sep 1, 2006 | Hospital de Leon, Rottapharm |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cairo University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| Daiwa Pharmaceutical Corporation | For profit | 1 | 0 | 1 | 2012 |
| Hospital de Leon | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Rottapharm | For profit | 1 | 1 | 1 | 2006 |
| University of California, Los Angeles | Academic/Hospital | 1 | 0 | 1 | 2012 |
5 organizations
Page 1 / 1